US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist
  • 1.820
  • -0.055-2.93%
Trading Nov 4 15:35 ET
147.33MMarket Cap-4000P/E (TTM)

Innate Pharma Key Stats

Innate Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--
DatePeriodRevenue/EstimateEarnings Call
Mar 10, 20202019/Q413.330M / 22.402M--
--2019/Q313.330M / 24.747M--
Sep 13, 20192019/Q229.580M / 43.206M--
--2019/Q1-- / 43.206M--
--------

Unlock Free Earnings Estimates

Innate Pharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data